TrademarkDir
PETERTHOMASROTH CLINICAL SKIN CARE MAX VITAMIN D-FENSE
DEAD

Serial Number

97508517

Owner

Peter Thomas Roth Labs LLC

Attorney

Christine M. Baker

Filing Date

Jul 18, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PETERTHOMASROTH CLINICAL SKIN CARE MAX VITAMIN D-FENSE Trademark

Serial Number: 97508517

PETERTHOMASROTH CLINICAL SKIN CARE MAX VITAMIN D-FENSE is a trademark filed by Peter Thomas Roth Labs LLC on July 18, 2022. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Peter Thomas Roth Labs LLC (107 trademarks)

16th Floor
New York, NY 10022

Entity Type: 99

Trademark Details

Filing Date

July 18, 2022

Registration Date

Not Registered

Published for Opposition

March 19, 2024

Goods & Services

Medicated sunscreen preparations containing a synthetic vitamin D analog ingredient

Non-medicated sunscreen preparations containing a synthetic vitamin D analog ingredient

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 13, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 13, 2025 AITU
SOU EXTENSION 1 FILED
Nov 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 14, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 8, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 9, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 9, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 9, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 24, 2023 GPRN
PRIORITY ACTION E-MAILED
Apr 24, 2023 GPRA
PRIORITY ACTION WRITTEN
Apr 24, 2023 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2023 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 28, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 28, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Dec 28, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Dec 28, 2022 CPEA
EXAMINER'S AMENDMENT ENTERED
Dec 21, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 21, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 21, 2022 CNEA
ASSIGNED TO EXAMINER
Dec 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2022 NWOS
NEW APPLICATION ENTERED
Jul 21, 2022 NWAP

Related Trademarks

More from this Owner

CLINI-CAL

CLINI-CAL

CLINI-CAL

CLINI-CAL

CLINI-CAL

CLINI-CAL

PEPTIDE SKINJECTION

PEPTIDE SKINJECTION

PEPTIDE SKINJECTION

PEPTIDE SKINJECTION

PEPTIDE SKINJECTION

PEPTIDE SKINJECTION